February is heart month, a time to think about the health of your and your loved ones’ arteries. If arteries get stressed by ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Alcohol use disorder, which affects over 10% of Americans, can lead to persistent and serious insomnia. Difficulties falling asleep and staying asleep ...

Terence Flynn, Morgan Stanley, inquired about Zepbound payer dynamics and access. Patrik Jonsson explained that Medicare coverage related to obstructive sleep apnea (OSA) is anticipated in the second ...

Since iOS 18 was released in September 2024, Apple has introduced an unprecedented number of new features and improvements ...

A new OU Health Sciences initiative fueled by a federal grant is sending PA students on three-month rotations in rural ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Memsi, which contains 'cathinone' as one of its main ingredients - shares this ingredient with Captagon, utilized by Hamas ...

Two major new studies from the Columbia University Mailman School of Public Health reveal that veterans of the Vietnam War continue to face ...

Smart home healthcare market growth is driven by rising consumer adoption of smart devices, advancements in wearables and remote monitoring, and cost-effective healthcare solutions.New Delhi, Feb. 06, ...